The April 13th Transition: Why a Phone Call Isn’t Enough for DME Claims


If you are a pharmacy or DME provider, your workflow is about to experience a significant shift. On April 13, 2026, CMS is officially updating the Required Face-to-Face Encounter and Written Order Prior to Delivery List. This isn't just a minor update; it adds 83 high-volume items—including stationary and portable oxygen systems like E0424 and E1390—to the list of products that require a Face-to-Face Encounter and a Written Order Prior to Delivery. If you deliver these items after the April deadline based on a simple phoned-in script from a doctor, your claim will face an automatic system-wide denial.

Under these new rules, the treating physician must have a documented face-to-face visit with the patient within the six months prior to writing the order. This encounter must be recorded in the medical notes, specifically detailing the medical necessity for the equipment. Furthermore, you must have the Standard Written Order physically in your possession before the equipment leaves your building. You can no longer catch up on paperwork after the delivery is made. For providers in all 50 states, this means your intake process must change immediately to verify these dates before you even pull inventory from the shelf.

The 2026 audit environment is no longer human-led; it is code-led. When you submit a claim for an item on this required list, the payer’s computer immediately looks for the date of the face-to-face encounter and the date of the written order. If those dates don't align perfectly with the delivery date, the claim is rejected as a contractual error. This shift to automated enforcement means you won't get a chance to explain the situation to a representative later. The system simply stops your payment at the source.

To avoid a massive spike in rejected claims this spring, it is vital to audit your current pending orders now. Any oxygen system or orthotic device scheduled for delivery on or after April 13th must meet these strict documentation standards. Relying on the way things have always been done will result in a total loss of reimbursement for those items. Ensuring your digital records are synced with these new CMS-6097-N requirements is the only way to protect your revenue as these new requirements go live nationwide.

_____________________________________________________________________________________

Investigative Dispatch: February 2026 This article is a matter of professional record, verified for current regulatory standing and authorized for distribution by:

Sterling Bly Investigative Blogger


PACCS

Popular posts from this blog

The 2026 Visibility Alert: Protecting Your Pharmacy or DME Practice from Automated Directory Removal

Image
                      The Distinction Between Payer Directory Attestations and Medicare PDM In the current 2026 regulatory environment, providers must distinguish between two different types of data management. While the Medicare PECOS 2.0 Provider Data Management system governs your actual billing privileges and ownership records, the No Surprises Act mandates a separate 90-day attestation for private payer directories. For DMEPOS suppliers and pharmacies, missing a single 90-day cycle for these private plans does not just create a clerical error; it leads to the immediate removal of your facility from insurance directories. When a facility is removed from these directories, it appears as out-of-network to patients, leading to lost revenue and unnecessary claim delays even if your contract is technically still active. Mandatory 90-Day Verification Cycles for Private Insurance Networks The 90-day attestation requirement ...
Read more

The 180-Day Federal Moratorium: No New PTANs for DME Suppliers

Image
  The federal government has just fundamentally changed the environment for every medical supply provider in the country. On February 27, 2026, CMS officially enacted a nationwide six-month moratorium on all new Medicare enrollments for seven specific categories of suppliers. This is not a minor delay; it is a regulatory brick wall. For the first half of 2026, the issuance of new Provider Transaction Access Numbers, or PTANs, has effectively ceased under the CMS-6099-N notice. For a new business owner who just signed a lease or invested in inventory, this moratorium creates a devastating domino effect. The PTAN is the first domino in the line of professional credibility. Without an active Medicare enrollment, you cannot secure a Medicaid provider agreement, and most commercial insurance payers will not even look at your application for a contract. For a brand-new startup, this doesn't just mean a delay in Medicare payments; it means a total revenue blackout across almost every pay...
Read more

Is Your PTAN at Risk? Urgent February 14th National Inspector Transitio

Image
A significant shift in federal oversight became official this Saturday, February 14, 2026. Data from the field confirms that the Centers for Medicare & Medicaid Services (CMS) has officially transitioned site visits to new national contractors. Specifically, Signature Consulting Group has assumed responsibility for the Western United States, while Arch Systems, LLC manages the East. This replaces the regional inspectors who have managed facilities for years. The "Stop Button" Enforcement Trend The evidence from recent inspections suggests a move toward more rigid enforcement. Rather than providing corrective action plans for minor discrepancies, inspectors are moving directly toward deactivation. This "stop button" approach has immediate financial consequences. A deactivated Provider Transaction Access Number (PTAN) often triggers a secondary suspension within 48 hours from state Medicaid programs, resulting in a revenue blackout of 120 days or more while a ...
Read more